Dec 02, 2024
Novocure stock jumps on positive trial results for cancer therapy
On Monday, Novocure (NASDAQ: NVCR) experienced a significant surge in stock price, climbing 19%, following the announcement of successful results from its Phase 3 PANOVA-3 clinical...